Advertisement
Product › Details
PREOB® autologous bone cell therapy product
Next higher product group | autologous cell therapy product_o | |
Status | 2013-02-25 development p3 existent | |
Organisation | Bone Therapeutics S.A. (Euronext Brussels + Paris: BOTHE) | |
Group | Bone Therapeutics (Group) | |
Record changed: 2023-07-10 |
Advertisement
More documents for autologous cell therapy product_o
- [1] Evomedis GmbH. (11/23/23). "Press Release: Evomedis Announces Strategic Partnership with Medical University of Graz and COREMED Graz to Foster Wound Healing Innovation". Graz....
- [2] Evomedis GmbH. (5/12/23). "Press Release: European Commission Grants Orphan Drug Designation for EVOCellic"....
- [3] Bone Therapeutics S.A.. (11/7/18). "Press Release: Bone Therapeutics Business Update for Third Quarter 2018". Gosselies....
- [4] Bone Therapeutics S.A.. (11/6/18). "Press Release: Bone Therapeutics Announces Conclusions from Interim Analysis of Phase III PREOB Study in Hip Osteonecrosis". Gosselies....
- [5] Bone Therapeutics S.A.. (9/22/17). "Press Release: Bone Therapeutics and Asahi Kasei Sign Exclusive License Agreement for PREOB in Japan". Gosselies....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top